FDA Highlights Importance of DPD Deficiency Discussions With Patients Before Capecitabine or 5-FU Treatment

The FDA has provided a communication to increase awareness of recent updates to the product labeling of ...

MARCH 6, 2025

Pyrotinib Plus Chemotherapy May Improve Outcomes in Patients With Pretreated HER2-Positive Breast Cancer

Among patients with previously treated HER2-positive metastatic breast cancer, those treated with pyrotinib plus ...

MARCH 9, 2022

Ruxolitinib + Capecitabine Improves ORR But Not PFS or OS in HER2- Breast Ca With Elevated CRP

In patients with advanced HER2-negative breast cancer with elevated C-reactive protein (CRP) levels, adding ...

APRIL 28, 2017

Capecitabine + Cisplatin Shows Benefit in Heavily Pretreated Breast Ca

The combination of capecitabine and cisplatin  systemic chemotherapy demonstrates clinical benefit against ...

APRIL 28, 2017

Low-Dose Capecitabine Plus Docetaxel Offers Better PFS Than Docetaxel Alone

Low-dose capecitabine plus docetaxel demonstrated slightly better progression-free survival compared with ...

FEBRUARY 2, 2017

Bevacizumab + CAPOX Improves QOL After Resection of CRC Liver Mets

Adding bevacizumab to an adjuvant regimen of capecitabine and oxaliplatin (CAPOX) may improve the quality of life ...

JANUARY 30, 2017

Capecitabine Extends Survival After Pancreatic Cancer Surgery

Adding capecitabine to gemcitabine in adjuvant treatment of pancreatic cancer prolongs survival without increasing ...

JUNE 10, 2016